Bioengineered Artificial Skin Market Growth Accelerated by Increasing Incidents of Burn Injuries and Skin Defects



Bioengineered artificial skin products have gained traction over the past few years owing to their ability regenerate and replace damaged or defective skin tissues. These products are developed using cultured tissues obtained from autologous skin cells of patients. This process aids quick regeneration of functional tissues similar to the skin, preventing fluid loss, infection, and scarring. The global bioengineered artificial skin market demand has been fuelled by increasing incidence of burns, skin defects due to injuries, and genetic disorders.

The global bioengineered artificial skin market is estimated to be valued at US$ 1.2 billion in 2023 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2028, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The increasing cases of burn injuries and skin defects has been a prominent driver for the bioengineered artificial skin market growth over the past few years. According to the American Burn Association, there were over 450,000 burn injuries that required medical attention in 2021 alone in the United States. Moreover, genetic skin disorders such as Epidermolysis bullosa have also increased globally over time. Advancements in tissue engineering techniques aided by the use of stem cells and biomaterials have enabled production of bioengineered skin grafts similar to native skin tissues and accelerated the healing process. This has driven the demand for these products across hospitals and burn care centers.

Segment Analysis
The global bioengineered artificial skin market is dominated by the burn care segment, accounting for over 40% share in 2023. Burn care involves covering burned parts of the skin with artificial skin temporarily until the burned skin heals or gets replaced by healthy skin through skin grafting. Artificial skin acts as an effective barrier, preventing chances of infection and further damage to burned skin.

Key Takeaways
The global bioengineered artificial skin market is expected to witness high growth during the forecast period of 2023 to 2028 on account of rising incidence of burns, trauma injuries, and chronic wounds globally.

Regional analysis: North America reigns supreme in the bioengineered artificial skin market and is estimated to witness the fastest growth during the forecast period, progressing at a CAGR of over 17%. This can be attributed to advanced healthcare infrastructure, high adoption of modern medical technologies, and presence of major market players in the region.

Key players: Key players operating in the bioengineered artificial skin market are MiMedx, Smith & Nephew, Integra LifeSciences Corporation, Organogenesis, Mallinckrodt, Tissue Regenix, Nuo Therapeutics, Stratatech Corporation, and Mylan. MiMedx dominates the global market with over 30% share owing to its extensive Artificial Skin product portfolio for treating severe burns and wounds.

Comments

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management